Veracyte, Inc. (VCYT): Operating Income
$57.78M
Year ended 2025-12-31
$105.77M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $57.78M | +257.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $16.14M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$85.80M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$41.08M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$81.90M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$35.39M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$15.13M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$22.23M | n/m | 2021-02-22, From 2018-01-01 |
| 2017-12-31 | -$26.54M | n/m | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | -$28.80M | n/m | 2019-02-25, From 2016-01-01 |
| 2015-12-31 | -$33.47M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | -$29.01M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$23.17M | n/m | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | -$18.93M | n/m | 2015-03-25, From 2012-01-01 |
| 2011-12-31 | -$15.27M | n/a | 2014-03-20, From 2011-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Veracyte, Inc. (VCYT) | 2025-12-31 | $57.78M | +257.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$30.78M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | -$42.81M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $45.11M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$91.10M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $16.02M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$437.25M | n/m |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$562.16M | n/m |
| RadNet, Inc. (RDNT) | 2025-12-31 | $61.99M | -40.7% |
Compare VCYT, CDNA, CSTL, CAI side by side · Screen every company in Services-Medical Laboratories ↗